California-based Tenaya Therapeutics, a biotech seeking to discover, develop and deliver potentially curative therapies that ...

One of the biggest challenges to the cell and gene therapy (CGT) landscape over the last couple of years has been the ...

Results from the PERSEUS Phase III study showed that tolebrutinib did not meet its primary endpoint in delaying time to ...

US biopharma Arcus Biosciences has announced the discontinuation of the Phase III STAR-221 study, being conducted in ...

Swedish Orphan Biovitrum, also known as Sobi, has entered into a definitive agreement to acquire San Diego, USA-based biotech ...

On December 12, 2025, the US Food and Drug Administration approved Johnson & Johnson subsidiary Janssen Biotech’s Akeega (niraparib and abiraterone acetate with prednisone for adults with deleterious ...

Swedish rare disease specialist Hansa Biopharma announced a reorganization of its European and International Commercial and ...

Japan’s Tanabe Pharma, formerly known as Mitsubishi Tanabe and now owned by Bain Capital, has obtained approval from the ...

M&A news last week featured Mirum Pharmaceuticals announcing plans to acquire fellow USA-based Bluejay Therapeutics and its ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...